Document:

<PAGE>

                                                                    EXHIBIT 10.4

                          REGISTRATION RIGHTS AGREEMENT

     This Registration Rights Agreement (this "Agreement") is made and entered
into as of this 9th day of August, 2002 by and between Interleukin Genetics,
Inc., a Delaware corporation (the "Company"), and the "Investors" party to those
Note and Warrant Subscription Agreements of by and between the Company and each
Investors (the "Subscription Agreements"). Capitalized terms used herein and not
otherwise defined herein shall have the meanings ascribed to them in the
Subscription Agreements.

     The parties hereby agree as follows:

     1.  CERTAIN DEFINITIONS.

          As used in this Agreement, the following terms shall have the
following meanings:

          "COMMON STOCK" shall mean the Company's Common Stock, par value $0.001
per share.

          "INVESTORS" shall mean the Investors party to the Subscription
Agreements and each Person to whom Registrable Securities have been duly
assigned in accordance with the terms of this Agreement.

          "PERSON" means an individual, corporation, partnership, trust,
business trust, association, joint stock company, joint venture, pool,
syndicate, sole proprietorship, unincorporated organization, governmental
authority or any other form of entity not specifically listed herein.

          "PROSPECTUS" shall mean the prospectus included in any Registration
Statement, as amended or supplemented by any prospectus supplement, with respect
to the terms of the offering of any portion of the Registrable Securities
covered by such Registration Statement and by all other amendments and
supplements to the prospectus, including post-effective amendments and all
material incorporated by reference in such prospectus.

          "REGISTER," "REGISTERED" and "REGISTRATION" refer to a registration
made by preparing and filing a registration statement or similar document in
compliance with the 1933 Act (as defined below), and the declaration or ordering
of effectiveness of such registration statement or document.

          "REGISTRABLE SECURITIES" shall mean the Warrant Shares (as such term
is defined in the Subscription Agreements).

          "REGISTRATION STATEMENT" shall mean a shelf registration statement on
Form S-3 (or, if Form S-3 is not then available to the Company, on such form of
registration statement as is then available to effect a registration for resale
of the Registrable Securities) of the Company filed under the 1933 Act that
covers the resale of the Registrable Securities pursuant to the provisions of
this Agreement, together with all amendments and supplements thereto, including

<PAGE>

post-effective amendments, all exhibits and all material incorporated by
reference in such Registration Statement.

          "SEC" means the U.S. Securities and Exchange Commission.

          "1933 ACT" means the Securities Act of 1933, as amended, and the rules
and regulations promulgated thereunder.

          "1934 ACT" means the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder.

     2.  REGISTRATION.

          (a) SHELF REGISTRATION. Within one (1) year after the closing of the
transactions contemplated under the Subscription Agreements, the Company agrees
to file with the SEC the Registration Statement with respect to the registration
under the 1933 Act for resale of the Registrable Securities. The Company will
use its reasonable best efforts to cause the Registration Statement to be
declared effective under the 1933 Act as promptly as practicable. The Company
will use its reasonable best efforts to keep the Registration Statement
continuously effective until the earliest of (a) the date when all of the
Registrable Securities covered thereby have been sold thereunder or pursuant to
Rule 144 (including but not limited to sales pursuant to Rule 144(k)) under the
1933 Act; (b) the date on which the Investors owning a majority of the
Registrable Securities agree to the withdrawal of the Registration Statement; or
(c) the first date on which all of the shares of Registrable Securities covered
thereby could be sold either (i) pursuant to Rule 144(k) under the 1933 Act or
any successor thereto or (ii) in any three month period pursuant to Rule 144
under the 1933 Act or any successor rule thereto (the "SHELF REGISTRATION
PERIOD"). The Company further agrees to supplement or make amendments to the
Registration Statement, if required by the rules, regulations, or instructions
applicable to the registration form utilized by the Company or by the 1933 Act
or rules and regulations thereunder for the Registration Statement.

          (b) EXPENSES. All Registration Expenses incident to the Company's
performance of or compliance with this Agreement shall be paid by the Company.
The term "Registration Expenses" includes without limitation all registration
filing fees, reasonable professional fees and other reasonable expenses of the
Company's compliance with federal, state and other securities laws, printing
expenses, messenger, telephone and delivery expenses; reasonable fees and
disbursements of counsel for the Company; reasonable fees and disbursements of
the Company's independent certified public accountants (including the expenses
of any audit or "comfort" letters required by or incident to performance of the
obligations contemplated by this Agreement); and applicable stock exchange and
NASD registration and filing fees. The term "Registration Expenses" does not
include any discounts or commissions to any broker attributable to the sale of
Registrable Securities or any fees (including but not limited to attorney fees)
or expenses incurred by any Investor in connection with this Agreement.

                                      -2-

<PAGE>

          (c) BLACKOUT PERIOD. If (i) there is material non-public information
regarding the Company which the Company's Board of Directors (the "Board")
reasonably determines not to be in the Company's best interest to disclose at
such time, or (ii) there is a significant business opportunity (including, but
not limited to, the acquisition or disposition of assets (other than in the
ordinary course of business) or any merger, consolidation, tender offer or other
similar transaction) available to the Company which the Board reasonably
determines not to be in the Company's best interest to disclose at such time and
which the Company would be required to disclose under the Registration
Statement, then the Company may suspend effectiveness of the Registration
Statement and suspend the sale of Registrable Securities under the Registration
Statement (a "Blackout Period"); PROVIDED, that the Company may not suspend such
obligations pursuant to this Section 2(c) for more than one hundred and eighty
(180) days in the aggregate during any twelve (12) month period.

     3.  COMPANY OBLIGATIONS. The Company shall use its reasonable best efforts
to register and to permit the sale of the Registrable Securities in accordance
with the intended method of disposition. To carry out this obligation, the
Company shall as expeditiously as practicable:

          (a) prepare and file with the SEC the Registration Statement within
one (1) year following the closing of the transactions contemplated in the
Subscription Agreements and use commercially reasonable efforts to cause the
Registration Statement to become effective. At least five (5) business days
before filing the Registration Statement or prospectus or at least three (3)
business days before filing any amendments or supplements thereto, the Company
will furnish to the Investors copies of all documents proposed to be filed;

          (b) immediately notify the Investors of any stop order threatened or
issued by the SEC and take all actions reasonably required to prevent the entry
of a stop order or if entered to have it rescinded or otherwise removed;

          (c) prepare and file with the SEC such amendments and supplements to
the Registration Statement and the corresponding prospectus necessary to keep
the Registration Statement effective for the Shelf Registration Period; and
comply with the provisions of the 1933 Act with respect to the disposition of
all securities covered by the Registration Statement during such period in
accordance with the Investor's intended methods of disposition as set forth in
the Registration Statement;

          (d) furnish to each Investor such number of copies of the Registration
Statement, each amendment and supplement thereto (in each case including all
exhibits), the corresponding prospectus (including each preliminary prospectus),
and such other documents as such Investor may reasonably request to facilitate
the disposition of such Investor's Registrable Securities;

(e) use its
reasonable best efforts to register or qualify the Registrable Securities under
such securities or blue sky laws of jurisdictions in the United States of
America as any Investor reasonably requests and do any and all other reasonable
acts and things that may be necessary or advisable to enable a Investor to
consummate the disposition of the Investor's Registrable Securities in such
jurisdiction; provided, however, that the Company shall not be

                                      -3-

<PAGE>

obligated to qualify as a foreign corporation to do business under the laws of
any jurisdiction in which it is not then qualified or where such qualification
would subject it to taxation or to take any action which would subject it to
general service of process in any jurisdiction where it is not now so subject;

          (f) notify each Investor, at any time when a prospectus is required to
be delivered under the 1933 Act, of the occurrence of any event as a result of
which the prospectus or any document incorporated therein by reference contains
an untrue statement of a material fact or omits to state any material fact
necessary to make the statements therein not misleading in light of the
circumstances under which such statements were made, and, except during any
Blackout Period, prepare a supplement or amendment to the prospectus or any such
document incorporated therein so that thereafter the prospectus will not contain
an untrue statement of a material fact or omit to state any material fact
necessary to make the statements therein not misleading in light of the
circumstances under which such statements were made;

          (g) use its reasonable best efforts to cause all registered
Registrable Securities to be listed on each securities exchange, if any, on
which similar securities issued by the Company are then listed, or cause all
registered Registrable Securities to be authorized for trading on NASDAQ if
similar securities issued by the Company are then so authorized, as the case may
be; and

          (h) take all other steps reasonably necessary to effect the
registration and resale of the Registrable Securities contemplated hereby in
accordance with the terms of this Agreement.

     4.  RULE 144. The Company covenants that it will file the reports required
to be filed by it under the 1933 Act and the 1934 Act and the rules and
regulations adopted by the SEC thereunder, and it will take such further action
as each Investor reasonably may request, all to the extent required from time to
time, to enable each Investor to sell Registrable Securities without
registration under the 1933 Act within the limitation of the exemptions provided
by (a) Rule 144 under the 1933 Act, or (b) any similar rule or regulation
hereafter adopted by the SEC. Upon the request of an Investor, the Company will
deliver to such Investor a written statement as to whether it has complied with
Rule 144's or any successor rules' requirements. The Company also covenants that
in such event it will provide all such information and it will take such further
action as such Investor reasonably may request to enable such Investor to sell
Registrable Securities without registration under the 1933 Act within the
limitation of Rule 144 under the 1933 Act or any successor rule requirements.

     5.  OBLIGATIONS OF THE INVESTORS.

          (a) INVESTOR INFORMATION. The Company may require each Investor to
furnish to the Company information regarding each such Investor and the
distribution of the securities subject to the registration, and such Investors
shall furnish all such information reasonably requested by the Company. If the
Registration Statement or Prospectus contained therein, refers to any Investor
by name or otherwise as the Investor of any securities of the Company, then such
Investor shall promptly notify the Company if any fact occurs with respect

                                      -4-

<PAGE>

to the information furnished by the Investor to the Company, or any information
approved by such Investor or its authorized representative for inclusion in the
Registration Statement or any Prospectus, regarding such Investor and the
distribution of the securities subject to registration owned by such Investor
which results in the Registration Statement or the Prospectus containing an
untrue statement of material fact with respect to such information or omitting
to state a material fact with respect to such information required to be stated
therein or necessary to make the statements therein with respect to such
information not misleading and shall provide to the Company such information as
shall be necessary to enable the Company to prepare a supplement or
post-effective amendment to such Registration Statement or Prospectus or any
document incorporated therein by reference or file any other document required
so that the Registration Statement or Prospectus will not contain an untrue
statement of a material fact with respect to such information or omit to state a
material fact with respect to such information required to be stated therein.

          (b) INVESTOR OBLIGATIONS. Each Investor covenants and agrees to (i)
comply with all prospectus delivery requirements of the 1933 Act and with all
anti-stabilization, anti-manipulation and similar provisions of Section 10 of
the 1934 Act and any rules issued thereunder by the SEC, and to furnish to the
Company information about sales made in such public offering and (ii) at the end
of the Shelf Registration Period discontinue sales of shares pursuant to the
Registration Statement and advise the Company of the number of Registrable
Securities remaining unsold.

          (c) NOTICE TO DISCONTINUE. Each Investor agrees by acquisition of
Registrable Securities that, upon receipt of any notice from the Company of any
event of the kind described in Section 3(f), each Investor will discontinue
disposition of Registrable Securities until such Investor receives copies of the
supplemented or amended prospectus contemplated by Section 3(f). In addition, if
the Company requests, each Investor will deliver to the Company (at the
Company's expense) all copies, other than permanent file copies then in such
Investor's possession, of the prospectus covering the Registrable Securities
current at the time of receipt of the notice.

     6.  INDEMNIFICATION.

          (a) INDEMNIFICATION BY COMPANY. The Company agrees to indemnify and
hold harmless, to the fullest extent permitted by law the Investors, each of
their officers, directors, partners and employees and each person who controls
the Investors (within the meaning of the 1933 Act) against all losses, claims,
damages, liabilities, costs (including, without limitation, reasonable
attorney's fees) and expenses imposed on such person caused by (i) any untrue or
alleged untrue statement of a material fact contained in any Registration
Statement or Prospectus or any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, except insofar as the same are based upon any
information furnished in writing to the Company by such Investors, expressly for
use therein or relates to such Investor or such Investor's proposed method of
distribution of Registrable Securities and was approved by such Investor or its
authorized representative for use in the Registration Statement or Prospectus,
or (ii) any violation by the Company of the 1933 Act, the 1934 Act, any state
securities or blue sky law or any rule or

                                      -5-

<PAGE>

regulation thereunder applicable to the Company in connection with any
Registration Statement or Prospectus, and shall reimburse in accordance with
subparagraph (c) below, each of the foregoing persons for any legal and any
other expenses reasonably incurred in connection with investigating or defending
any such claims. The foregoing is subject to the condition that, insofar as the
foregoing indemnities relate to any untrue statement, alleged untrue statement,
omission or alleged omission made in any preliminary prospectus or Prospectus
that is eliminated or remedied in any Prospectus or amendment or supplement
thereto, the above indemnity obligations of the Company shall not inure to the
benefit of any indemnified party if a copy of such corrected Prospectus or
amendment or supplement thereto had been made available to such indemnified
party and was not sent or given by such indemnified party at or prior to the
time such action was required of such indemnified party by the 1933 Act and if
delivery of such Prospectus or amendment or supplement thereto would have
eliminated (or been a sufficient defense to) any liability of such indemnified
party with respect to such statement or omission. Indemnity under this Section
5(a) shall remain in full force and effect regardless of any investigation made
by or on behalf of any indemnified party and shall survive the permitted
transfer of the Registrable Securities.

          (b) INDEMNIFICATION BY INVESTOR. In connection with any registration
pursuant to the terms of this Agreement, each Investor will furnish to the
Company in writing such information as the Company reasonably requests
concerning the holders of Registrable Securities or the proposed manner of
distribution for use in connection with any Registration Statement or Prospectus
and agrees, severally but not jointly, to indemnify and hold harmless, to the
fullest extent permitted by law, the Company, its directors, officers,
employees, stockholders and each person who controls the Company (within the
meaning of the 1933 Act) against any losses, claims, damages, liabilities and
expense (including reasonable attorney's fees) resulting from or arising out of
(i) any failure by the Investor to comply with the prospectus delivery
requirements or (ii) any untrue statement of a material fact or any omission of
a material fact required to be stated in the Registration Statement or
Prospectus or preliminary prospectus or amendment or supplement thereto or
necessary to make the statements therein not misleading, to the extent, but only
to the extent that such untrue statement or omission is contained in any
information furnished in writing by such Investor to the Company specifically
for inclusion in such Registration Statement or Prospectus or amendment or
supplement thereto or relates to such Investor or such Investor's proposed
method of distribution of Registrable Securities and was approved by such
Investor or its authorized representative for use in the Registration Statement
or Prospectus.

          (c) CONDUCT OF INDEMNIFICATION PROCEEDINGS. Any person entitled to
indemnification hereunder shall (i) give prompt notice to the indemnifying party
of any claim with respect to which it seeks indemnification and (ii) permit such
indemnifying party to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified party; PROVIDED that any person entitled to
indemnification hereunder shall have the right to employ separate counsel and to
participate in the defense of such claim, but the fees and expenses of such
counsel shall be at the expense of such person unless (a) the indemnifying party
has agreed to pay such fees or expenses, or (b) the indemnifying party shall
have failed to assume the defense of such claim and employ counsel reasonably
satisfactory to such person or (c) the indemnified person

                                      -6-

<PAGE>

shall have been advised by counsel that a conflict of interest exists between
such person and the indemnifying party with respect to such claims (in which
case, if the person notifies the indemnifying party in writing that such person
elects to employ separate counsel at the expense of the indemnifying party, the
indemnifying party shall not have the right to assume the defense of such claim
on behalf of such person); and PROVIDED, FURTHER, that the failure of any
indemnified party to give notice as provided herein shall not relieve the
indemnifying party of its obligations hereunder, except to the extent that such
failure to give notice shall materially adversely affect the indemnifying party
in the defense of any such claim or litigation. It is understood that the
indemnifying party shall not, in connection with any proceeding in the same
jurisdiction, be liable for fees or expenses of more than one separate firm of
attorneys at any time for all such indemnified parties. If the indemnifying
party does not assume the defense, the indemnifying party will not be liable for
any settlement made without its consent (but that consent may not be
unreasonably withheld). No indemnifying party will, except with the consent of
the indemnified party, consent to entry of any judgment or enter into any
settlement (a) that does not include as an unconditional term thereof the giving
by the claimant or plaintiff to such indemnified party of a release from all
liability in respect of such claim or litigation or (b) that contains any
admission of guilt on the part of any indemnified party.

          (d) CONTRIBUTION. If for any reason the indemnification provided for
in the preceding paragraphs (a) and (b) is unavailable to an indemnified party
or insufficient to hold it harmless, other than as expressly specified therein,
then the indemnifying party shall contribute to the amount paid or payable by
the indemnified party as a result of such loss, claim, damage or liability in
such proportion as is appropriate to reflect the relative fault of the
indemnified party and the indemnifying party, as well as any other relevant
equitable considerations. No person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the 1933 Act shall be entitled to
contribution from any person not guilty of such fraudulent misrepresentation. In
no event shall the contribution obligation of a holder of Registrable Securities
be greater in amount than the dollar amount of the proceeds (net of all expenses
paid by such holder and the amount of any damages such holder has otherwise been
required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities
giving rise to such contribution obligation.

     7.  MISCELLANEOUS.

          (a) AMENDMENTS AND WAIVERS. This Agreement may be amended only by a
writing signed by the parties hereto. The Company may take any action herein
prohibited, or omit to perform any act herein required to be performed by it,
only if the Company shall have obtained the written consent to such amendment,
action or omission to act, of Investors holding a majority of the Registrable
Shares.

          (b) NOTICES. All notices and other communications provided for or
permitted hereunder shall be made as set forth in Section O of the Subscription
Agreements.

          (c) RECAPITALIZATIONS, EXCHANGES, ETC. The provisions of this
Agreement shall apply to the full extent set forth herein with respect to (a)
the Registrable Securities held by each Investor, (b) any and all shares of
capital stock of the Company into which such Registrable

                                      -7-

<PAGE>

Securities are converted, exchanged or substituted in any recapitalization or
other capital reorganization by the Company, and (c) any and all equity
securities of the Company or any successor or assign of the Company (whether by
merger, consolidation, sale of assets or otherwise) which may be issued in
respect of, in conversion of, in exchange for or in substitution of, such
Registrable Securities. The provisions of this Agreement shall be deemed
appropriately adjusted for any stock dividends, splits, reverse splits,
combinations, recapitalizations and the like occurring after the date hereof. If
requested by an Investor, the Company shall use its best efforts to cause any
successor or assign (whether by sale, merger or otherwise) to enter into a new
registration rights agreement with such Holder on terms substantially the same
as this Agreement as a condition of any such transaction, provided that the
absence of such new agreement shall not alter in any respect the obligations of
the successor or assign under this Agreement by virtue of the operation of
clause Section 7(d) below.

          (d) BENEFIT OF PARTIES; ASSIGNMENT. All of the terms and provisions of
this Agreement shall be binding on and inure to the benefit of the parties and
their respective successors including any successor to the Company or its
business (whether by way of sale, merger or otherwise) and permitted assigns.
Assigns of an Investor shall be considered "permitted assigns" and therefore
Investors under this Agreement only if Registrable Securities hereunder have
been assigned, in whole or in part, upon notice to the Company, by an Investor
to such assign (i) in whose hands such Registrable Securities are not
transferable pursuant to Section 4(1) of the Securities Act, (ii) who has agreed
in writing to be bound by the terms of this Agreement, and (iii) a copy of whose
agreement to be bound by this Agreement and the name and address of such
assignee have been furnished to the Company within a reasonable time after such
assignment.

          (e) COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

          (f) TITLES AND SUBTITLES. The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

          (g) SEVERABILITY. If one or more provisions of this Agreement are held
to be unenforceable under applicable law, such provision shall be excluded from
this Agreement and the balance of this Agreement shall be interpreted as if such
provision were so excluded and shall be enforceable in accordance with its terms
to the fullest extent permitted by law.

          (h) FURTHER ASSURANCES. The parties shall execute and deliver all such
further instruments and documents and take all such other actions as may
reasonably be required to carry out the transactions contemplated hereby and to
evidence the fulfillment of the agreements herein contained.

          (i) ENTIRE AGREEMENT. This Agreement is intended by the parties as a
final expression of their agreement and intended to be a complete and exclusive
statement of the agreement and understanding of the parties hereto in respect of
the subject matter contained

                                      -8-

<PAGE>

herein. This Agreement supersedes all prior agreements and understandings
between the parties with respect to such subject matter.

          (j) APPLICABLE LAW. This Agreement shall be governed by, and construed
in accordance with, the laws of The Commonwealth of Massachusetts without regard
to principles of conflicts of law.

                                      -9-

<PAGE>

     IN WITNESS WHEREOF, the parties have executed this Registration Rights
Agreement as of the date first written above.

The Company:                          INTERLEUKIN GENETICS, INC.

                                      By:
                                         ---------------------------------------
                                      Name:
                                      Title:

                                      -10-

<PAGE>

           [INVESTOR SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT]

Investor Name:
              ---------------------------

                                            (For Co-owners, if applicable)

By:
   ----------------------------------       ------------------------------------
Signature                                   Signature

Name                                        Name:
Title:                                      Title:

                                      -11-<PAGE>

                              EMPLOYMENT AGREEMENT
                             LAMSON RHEINFRANK, JR.

                 Exhibit 4.1 - Amended as of September 17, 2002

                                  COMPENSATION

1.   Base Salary. During the Employment Period, Employer shall pay to Executive
     a Base Salary, payable in equal monthly installments at such times during
     each month as is customary with Employer with respect to its senior
     executives, at a rate of $191,200 per annum.

2.   Short-Term Bonus Arrangement Applicable for Fiscal Year 2002.

     (a) Executive shall be entitled to receive an annual cash bonus for fiscal
         year 2002 based on the consolidated earnings per share of Employer
         ("EPS") as determined under the following Annual Cash Incentive Matrix:

<TABLE>
<CAPTION>
      ========================================================================================
                          ANNUAL CASH INCENTIVE MATRIX
      ----------------------------------------------------------------------------------------
      FISCAL YEAR              EPS/BONUS                EPS/BONUS               EPS/BONUS
      ----------------------------------------------------------------------------------------
      <S>                   <C>                     <C>                     <C>
         2002                $0.98/$20,000            $1.18/$40,000           $1.28/$100,000
      ========================================================================================
</TABLE>

     (b) An annual cash bonus shall not be payable for fiscal year 2002 if EPS
         for such fiscal year is less than $0.98.

     (c) If the EPS for fiscal 2002 is between the EPS levels shown in the above
         matrix, the amount of the annual cash bonus shall be prorated between
         such EPS levels. The maximum annual cash bonus for fiscal year 2002 is
         $100,000.

3.   Short-Term Bonus Arrangement Applicable for Fiscal Years 2003 and 2004.

     (a) Fiscal 2002 actual results, exclusive of the $0.19 per share
         non-recurring charge related to adoption of SFAS 242, will serve as the
         baseline for establishing the fiscal 2003 and 2004 bonus matrix. Under
         this matrix, incremental bonus payments will be made based on EPS
         improvements of 8%, 15% and 20% (exclusive of the one-time charge). In
         the following example, fiscal 2002 results are assumed to be $1.05 per
         share. Based upon $1.05 in fiscal 2002 EPS, the annual cash incentive
         matrix for the three-year period would be structured as follows:

<PAGE>

<TABLE>
<CAPTION>
====================================================================================================
                          ANNUAL CASH INCENTIVE MATRIX
----------------------------------------------------------------------------------------------------
                           8% EPS IMPROVE/           15% EPS IMPROVE/          20% EPS IMPROVE/
    FISCAL YEAR                BONUS %                   BONUS %                   BONUS %
----------------------------------------------------------------------------------------------------
<S>                       <C>                        <C>                       <C>
        2002              $0.98/$20,000              $1.18/$40,000             $1.28/$100,000
----------------------------------------------------------------------------------------------------
        2003              $1.34/$20,000              $1.43/$40,000             $1.49/$100,000
----------------------------------------------------------------------------------------------------
        2004              $1.45/$20,000              $1.64/$40,000             $1.79/$100,000
----------------------------------------------------------------------------------------------------
     Cumulative           $3.77/$60,000              $4.25/$120,000            $4.56/$300,000
====================================================================================================
</TABLE>

     (b) An annual cash bonus shall not be payable for fiscal year 2003 or
         fiscal 2004 if EPS for such fiscal year is less than the minimum level
         for each year as reflected in the matrix.

     (c) If the EPS for fiscal 2003 or fiscal 2004 is between the EPS levels
         reflected in the approved matrix, the amount of the annual cash bonus
         shall be prorated between such EPS levels. The maximum annual cash
         bonus for fiscal 2003 and fiscal 2004 is $100,000.

4.   Short-Term Bonus - Three-Year Cumulative Provision. Due to the cyclical
     nature of the Company's business, the matrix will be structured to include
     a three-year cumulative catch-up provision

     The amount of the annual cash bonus for fiscal year 2004 may be increased
     from the amounts determined in the matrix for such year as a result of the
     cumulative three-year EPS. The following example illustrates how the annual
     cash bonus for fiscal year 2004 may be increased by the cumulative
     three-year EPS (assuming the example matrix presented in item 3 above which
     is reflective of fiscal 2002 EPS of $1.05).

<TABLE>
<CAPTION>
                                                   EPS            BONUS
                                                   ---            -----

<S>                                              <C>           <C>
     Fiscal Year 2002                            $ 1.05        $    27,000
     Fiscal Year 2003                            $ 1.32        $         0
     Fiscal Year 2004                            $ 1.70        $    64,000
                                                 ------        -----------
     Cumulative Three-Year Total                 $ 4.07        $    91,000
     Cumulative Adjustment                                     $     6,500 (additional amount paid in 2004)
                                                               -----------
     Cumulative Bonus Paid                                     $    97,500
</TABLE>

     The cumulative annual bonus for fiscal years 2002, 2003 and 2004 before
     cumulative adjustment would be $91,000. Because the cumulative three-year
     EPS of $4.07 is between $3.77 and $4.25, the cumulative three-year bonus
     amount attributable to $4.07 would be $97,500, a proration between
     $3.77/$60,000 and $4.25/$120,000. As such, an additional $6,500 would be
     payable in 2004 to bring the fiscal year 2004 bonus to $70,500 and the
     cumulative three-year bonus to $97,500.

5.   Short-Term Bonus - Timing of Payment. Employer shall pay to Executive the
     annual cash bonus payable, if any, within 75 days following the end of each
     fiscal year.

6.   Short-Term Bonus Arrangement(s) Applicable for Fiscal Years After 2004.
     Executive shall be entitled to receive annual cash bonuses for years after
     fiscal year 2004 under a bonus arrangement or arrangements to be determined
     by Employer which shall provide Executive an annual bonus opportunity of at
     least $100,000.

<PAGE>

7.   Long-Term Incentive Arrangement Applicable for Fiscal Years 2000, 2001 and
     2002. On November 9, 1999, Executive received a grant of options to
     purchase 18,000 shares of Company Common Stock. Pursuant to the
     Compensation Committee's grant to Executive, the options, to the extent not
     previously exercisable and vested, shall be immediately exercisable and
     vested upon the termination of the Employment Period by Employer without
     cause pursuant to Section 5.1, or by Executive for good reason pursuant to
     Section 5.3, if such termination occurs within three months prior to or
     twelve months after a Change in Control.

8.   Long-Term Incentive Arrangement Applicable for Fiscal Years 2003, 2004 and
     2005. On September 17, 2002, Executive received a grant of options to
     purchase 18,000 shares of Company Common Stock. Pursuant to the
     Compensation Committee's grant to Executive, the options, to the extent not
     previously exercisable and vested, shall be immediately exercisable and
     vested upon the termination of the Employment Period by Employer without
     cause pursuant to Section 5.1, or by Executive for good reason pursuant to
     Section 5.3, if such termination occurs within three months prior to or
     twelve months after a Change in Control.

9.   Long-Term Incentive Arrangement(s) Applicable for Fiscal Years After 2005.
     In each fiscal year after 2005, Executive shall be entitled to participate
     in a long-term incentive arrangement or arrangements to be determined by
     Employer, which arrangement or arrangements shall provide Executive an
     opportunity to earn an amount no less than the product of $50,000
     multiplied by the numbers of fiscal years to which the arrangement or
     arrangements relate.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00044-of-00352.parquet"}]]